Ryan D Gentzler

12PUBLICATIONS
48CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer cell biologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 02, 2025
Successful Treatment of Innumerable Untreated Brain Metastases With Trastuzumab Deruxtecan in Chemotherapy-Naïve HER2-Mutated Non-Small-Cell Lung Cancer.

Sara Young, Sean C Dougherty, Angela M DeRidder

|Mar 19, 2025
Osimertinib for uncommon EGFR mutations: herding UNICORNs in a field of horses.

Sean C Dougherty, Ryan D Gentzler

|Oct 24, 2024
Implications for practice: phase II/III trial of carboplatin and irinotecan for elderly patients with extensive-stage small-cell lung cancer in Japan.

Shipra Maheshwari, Ryan D Gentzler

|Sep 19, 2024
Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer.

Remziye E Wessel, Nardin Ageeb, Joseph M Obeid

|Jul 09, 2024
Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer.

Remziye E Wessel, Nardin Ageeb, Joseph M Obeid

|Aug 09, 2023
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399.

Ryan D Gentzler, Liza C Villaruz, John C Rhee

Pageof 2

Frequent Collaborators

3 joint publications

Timothy N J Bullock

2 joint publications

Christine Hann

2 joint publications

Sepideh Dolatshahi

2 joint publications

Gabriel F Hanson